Cancer cells compress intratumour vessels
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The delivery of therapeutic drugs to solid tumours may be impaired by structural and functional abnormalities in blood and lymphatic vessels. Here we provide evidence that proliferating cancer cells cause intratumour vessels to compress and collapse. By reducing this compressive mechanical force and opening vessels, cytotoxic cancer treatments have the potential to increase blood perfusion, thereby improving drug delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This results in uneven blood flow within the tumor, generating regions of chronic or intermittent hypoxia and regions of enhanced permeability and increased interstitial pressure, which can result in compression of tumor vessels and poor vascular perfusion, hampering drug delivery [27].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [27]
In the citing paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
In the citing paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
Citations
Cites
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Self-citationLymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Self-citationSolid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859
Self-citationMolecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Self-citation(1999) · PubMed · Cited by 348
Self-citationThe Second Valve System in Lymphatics
Schmid-Schönbein, G. W. (2003) · Lymphatic Research and Biology · doi:10.1089/15396850360495664 · Cited by 113
Solid stress facilitates spheroid formation: potential involvement of hyaluronan
Koike, C., McKee, T. D., Pluen, A., Ramanujan, S., Burton, K., Munn, L. L., Boucher, Y., & Jain, R. K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600158 · Cited by 83
Self-citationImproved microcirculation in irradiated tumours
Reinhold, H. S. (1971) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(71)90069-7 · Cited by 71
Arbiser, J. L., Raab, G., Rohan, R. M., Paul, S., Hirschi, K. K., Flynn, E. A., Price, E. R., Fisher, D. E., Cohen, C., & Klagsbrun, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65171-1 · Cited by 36
Research works printed but not linked: 2
- Boucher, Y. & Jain, R. K. Cancer Res. 52, 5110–5114 (1992).
- Griffon-Etienne, G., Boucher, Y., Brekken, C., Suit, H. D. & Jain, R. K. Cancer Res. 59, 3776–3782 (1999).
Cited by
Items 301–400 of 859
Gold Nanoshells in Biomedical Applications
Erickson, T. A., & Tunnell, J. W. (2009) · Wiley eBooks · doi:10.1002/9783527610419.ntls0150 · Cited by 58
Youden, B., Jiang, R., Carrier, A. J., Servos, M. R., & Zhang, X. (2022) · ACS Nano · doi:10.1021/acsnano.2c06337 · Cited by 56
Elie, N., Kaliski, A., PERONNEAU, P., Opolon, P., Roche, A. J., & Lassau, N. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.09.011 · Cited by 52
General Overview of Radioimmunotherapy of Solid Tumors
Navarro‐Teulon, I., Lozza, C., Pèlegrin, A., Vivès, É., & Pouget, J. (2013) · Immunotherapy · doi:10.2217/imt.13.34 · Cited by 57
da Cunha, C. B., Klumpers, D. D., Koshy, S. T., Weaver, J. C., Chaudhuri, O., Seruca, R., Carneiro, F., Granja, P. L., & Mooney, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.016 · Cited by 52
“The tumor mechanical microenvironment results from proliferative cancer cells straining the surrounding structural ECM (solid stress) [27-29], along with ECM remodeling and stiffening [3032].”
BackgroundCurrent progress in antivascular tumor therapy
Ho, Y.-J., Wang, T.-C., Fan, C., & Yeh, C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.001 · Cited by 57
The Mechanical Microenvironment in Breast Cancer
Pratt, S. J. P., Lee, R., & Martin, S. S. (2020) · Cancers · doi:10.3390/cancers12061452 · Cited by 57
“Compressive stress from the high cell proliferation characteristic of tumors can compress blood and lymphatic vasculature [200], and this solid stress induced vessel compression contributes to hypoxia and acts as a barrier to drug delivery in breast tumors [201].”
BackgroundFreeform 3D printing of vascularized tissues: Challenges and strategies
Lee, H., Jang, T., Han, G., Kim, H., & Jung, H. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211057236 · Cited by 52
Drasdo, D., & Hoehme, S. (2012) · New Journal of Physics · doi:10.1088/1367-2630/14/5/055025 · Cited by 50
“For example, it has been found that tumors and their associated stroma have a lower elasticity (higher Young’s modulus) than normal tissue [70] which enables them to more effectively compress and eventually collapse blood and lymphatic vessels in their vicinity [71] even though cancer cells themselves are usually soft…”
BackgroundFluctuations inpO2in Irradiated Human Melanoma Xenografts
Brurberg, K. G., Thuen, M., Ruud, E. M., & Rofstad, E. K. (2006) · Radiation Research · doi:10.1667/rr3491.1 · Cited by 50
Li, X., Meng, X., & Ye, Z. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.03.030 · Cited by 49
Alfonso, J. C. L., Köhn‐Luque, A., Stylianopoulos, T., Feuerhake, F., Deutsch, A., & Hatzikirou, H. (2016) · Scientific Reports · doi:10.1038/srep37283 · Cited by 53
“We assume that occlusion of tumour blood vessels only occurs for glioma cell densities greater than N/2, where N is the brain tissue carrying capacity [60].”
BackgroundSchmid, R., Schmidt, S. K., Detsch, R., Horder, H., Blunk, T., Schrüfer, S., Schubert, D. W., Fischer, L., Thievessen, I., Heltmann‐Meyer, S., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107993 · Cited by 54
The solid tumor microenvironment—Breaking the barrier for T cells
Şimşek, H., & Klotzsch, E. (2022) · BioEssays · doi:10.1002/bies.202100285 · Cited by 56
“[62,63] As a result, new vessels are formed within the tumor, but this vascularity is prominent with its abnormal and ineffective nature, such as hyperpermeability.[63,64] Subsequently, increased fluid and macromolecule (e.”
BackgroundChien, A. J., Illi, J., Ko, A. H., Korn, W. M., Fong, L. H., Chen, L.-M., Kashani–Sabet, M., Ryan, C. J., Rosenberg, J. E., Dubey, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0522 · Cited by 49
“Hyperpermeability leads to interstitial hypertension, hypoxia, and acidosis, which prevent the efficient delivery of chemotherapy into tumor cells (1).”
BackgroundMoradi Kashkooli, F., Soltani, M., & Hamedi, M.-H. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105399 · Cited by 47
Pharmacokinetics of therapeutic monoclonal antibodies used in oncology.
Levêque, D., Wisniewski, S., & Jehl, F. (2005) · PubMed · Cited by 53
Angiogenesis in Gynecological Cancers: Role of Neurotrophins
Garrido, M. P., Torres, I., Vega, M., & Romero, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00913 · Cited by 48
“These characteristics produce a decrease of blood flow and drug delivery, and increase the interstitial fluid pressure, the extravasation of blood components and the intravasation of tumor cells (30, 32).”
BackgroundSun, C., Jain, R. K., & Munn, L. L. (2007) · Annals of Biomedical Engineering · doi:10.1007/s10439-007-9377-8 · Cited by 51
Self-citationKe, T., Jeong, E., Wang, X., Feng, Y., Parker, D. L., & Lu, Z. (2007) · PubMed Central · Cited by 46
In vivo compression and imaging in mouse brain to measure the effects of solid stress
Nia, H. T., Datta, M., Seano, G., Zhang, S., Ho, W. W., Roberge, S., Huang, P., Munn, L. L., & Jain, R. K. (2020) · Nature Protocols · doi:10.1038/s41596-020-0328-2 · Cited by 51
Self-citationTemporal Heterogeneity in Blood Supply in Human Tumor Xenografts
Brurberg, K. G., Gaustad, J., Mollatt, C., & Rofstad, E. K. (2008) · Neoplasia · doi:10.1593/neo.08388 · Cited by 46
“It has been suggested that increased mechanical pressure induced by active tumor cell proliferation may cause such compressions [14].”
BackgroundModelling the Role of Angiogenesis and Vasculogenesis in Solid Tumour Growth
Stamper, I. J., Byrne, H. M., Owen, M. R., & Maini, P. K. (2007) · Bulletin of Mathematical Biology · doi:10.1007/s11538-007-9253-6 · Cited by 47
“Occlusion is believed to occur as a result of the increase in mechanical pressure exerted on the immature vessels by rapidly proliferating tumour cells (Griffon-Etienne et al., 1999; Helmlinger et al., 1997; Padera et al., 2004 ).”
BackgroundMolecular cancer cell responses to solid compressive stress and interstitial fluid pressure
Purkayastha, P., Jaiswal, M. K., & Lele, T. P. (2021) · Cytoskeleton · doi:10.1002/cm.21680 · Cited by 51
Xiang, Y., Chen, Q., Nan, Y., Liu, M., Xiao, Z., Yang, Y., Zhang, J., Ying, X., Long, X., Wang, S., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202312092 · Cited by 46
Influence of Initial Residual Stress on Growth and Pattern Creation for a Layered Aorta
Du, Y., Lü, C., Michel Destrade, A., & Chen, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-44694-2 · Cited by 47
“elsofresidualstressesinvivoandalsoonceunloaded[1, 2, 3, 4, 5, 6, 7]. Residual stresses are used for maintaining a self-balanced state,bytransferringphysicalsignalsandregulatingsomespecificbio-functions[8, 9, 10, 11]. It is fair to say that healthy biological performances rely heavily on appropriate levels of residual s…”
BackgroundRecent advances in tumor microenvironment associated therapeutic strategies and evaluation models
Haider, T., Sandha, K. K., Soni, V., & Gupta, P. N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111229 · Cited by 45
Lapi, S. E., Voller, T. F., & Welch, M. J. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.05.009 · Cited by 50
Zhu, P., #x2019, #x2019, Lu, H., Wang, M., Chen, K., Chen, Z., & Yang, L. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0491 · Cited by 50
Mathematical modelling of tumour growth and treatment
Fasano, A., BERTUZZI, A., & Gandolfi, A. (2007) · Springer eBooks · doi:10.1007/88-470-0396-2_3 · Cited by 51
“The network may be partially neutralised by the tumour itself if it builds up a pressure sufficiently high to close the lumen of the vessels, as recently pointed out in [ 64 ].”
BackgroundDaruwalla, J., Greish, K., Malcontenti-Wilson, C., Muralidharan, V., Iyer, A., Maeda, H., & Christophi, C. (2009) · Journal of Vascular Research · doi:10.1159/000165380 · Cited by 43
“Our data is in disagreement with this, since SMA-pirarubicin caused marked central necrosis in many tumors. The limiting factor in this case was incomplete and heterogeneous necrosis. Some studies have proposed that residual cells are supplied by oxygen and nutrients diffusing from the surrounding normal tissue. Altho…”
ResultEndocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology
Burks, H. E., Pashos, N. C., Martin, E. C., McLachlan, J. A., Bunnell, B. A., & Burow, M. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.010 · Cited by 47
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Nichols, J. W., Sakurai, Y., Harashima, H., & Bae, Y. H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.003 · Cited by 44
“The tumor vasculature is often collapsed owing to proliferative cancer cells and infiltrated stromal cells [56].”
BackgroundZhu, Y., Chen, J., Chen, C., Tang, R., Xu, J., Shi, S., & Yu, X. (2025) · Biomarker Research · doi:10.1186/s40364-025-00727-9 · Cited by 49
Tan, Y., Wang, H., Zhang, M., Quan, Z., Li, T., & He, Q. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12233 · Cited by 42
Molecular Imaging of Tumor Hypoxia with Positron Emission Tomography
Kelada, O. J., & Carlson, D. J. (2014) · Radiation Research · doi:10.1667/rr13590.1 · Cited by 46
Cai, Y., Wu, J., Li, Z., & Long, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150296 · Cited by 42
Zhu, Y., Yu, F., Tan, Y., Hong, Y. K., Meng, T., Liu, Y., Dai, S., Qiu, G., Yuan, H., & Hu, F. (2019) · Theranostics · doi:10.7150/thno.36334 · Cited by 43
“Total tissue pressure was strongly correlated with collagen area fraction across various tumor types and locations [50-52].”
Shojaee, P., Niroomand-Oscuii, H., Sefidgar, M., & Alinezhad, L. (2019) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2019.166089 · Cited by 45
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation
Cho, K., Ro, S. W., Lee, H. W., Moon, H., Han, S., Kim, H. R., Ahn, S. H., Park, J. Y., & Kim, D. Y. (2021) · Hepatology · doi:10.1002/hep.32000 · Cited by 46
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Regulation of Tumor Invasion by the Physical Microenvironment: Lessons from Breast and Brain Cancer
Beeghly, G. F., Amofa, K. Y., Fischbach, C., & Kumar, S. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110220-115419 · Cited by 46
Ader, I., Gstalder, C., Bouquerel, P., Golzio, M., Andrieu, G. P., Zalvidéa, S., Richard, S., Sabbadini, R. A., Malavaud, B. A., & Cuvillier, O. (2015) · Oncotarget · doi:10.18632/oncotarget.3144 · Cited by 45
Physical break-down of the classical view on cancer cell invasion and metastasis
Mierke, C. T. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.12.002 · Cited by 51
Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems
Zhu, D., Long, Q., Xu, Y., & Xing, J. (2019) · Micromachines · doi:10.3390/mi10060414 · Cited by 43
Biomaterials to regulate tumor extracellular matrix in immunotherapy
Zhang, Y., Dong, X., Zhang, Y., Chen, Z., Zhou, G., Chen, N., Shen, W., Yang, K., & Pei, P. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.010 · Cited by 42
Interstitial fluid—A reflection of the tumor cell microenvironment and secretome
Haslene‐Hox, H., Tenstad, O., & Wiig, H. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.01.028 · Cited by 43
Guo, J. X., Zeng, H., Shi, X., Han, T., Liu, Y., Liu, Y., Liu, C., Qu, D., & Chen, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01311-1 · Cited by 44
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model
Trédan, O., Lacroix‐Triki, M., Guiu, S., Mouret‐Reynier, M., Barrière, J., Bidard, F., Braccini, A.-L., Mir, O., Villanueva, C., & Barthélémy, P. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0334-9 · Cited by 43
Weibel, S., Raab, V., Yu, Y., Worschech, A., Wang, E., Marincola, F. M., & Szalay, A. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-68 · Cited by 39
“Recently, Padera et al [38] showed, that tumor-specific cytotoxic therapy results in more efficient drug delivery by decompressing collapsed vessels.”
BackgroundWang, G., Zhang, C., Li, M., Deng, K. Y., & Li, W. (2013) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e3182a21633 · Cited by 39
“Unau eventually leading to necrosis and strengthen degree reduction.(17) Yazdani and colleagues 18 explored the correlation between angiogenesis andmaturation of vessels in non-small-cell lung cancer and demonstrated that the degrees of maturation in newly formed blood vessels were less developed in inner areas of squ…”
BackgroundPhotodynamic Therapy for Pancreatic Ductal Adenocarcinoma
Karimnia, V., Slack, F. J., & Celli, J. P. (2021) · Cancers · doi:10.3390/cancers13174354 · Cited by 47
“One important consequence of the profound desmoplastic reaction in PDAC is the impact of compressive stress from accumulated fibrotic stroma, not only on cancer cells, but on blood and lymphatic vessels as well (Figure 4) [36].”
BackgroundPerfusion pressure is a critical determinant of the intratumoral extravasation of oncolytic viruses
Miller, A., Nace, R., Ayala-Breton C, C., Steele, M., Bailey, K., Peng, K. W., & Russell, S. J. (2016) · Molecular Therapy · doi:10.1038/mt.2015.219 · Cited by 38
Kirtane, A. R., Sadhukha, T., Kim, H., Khanna, V., Koniar, B., & Panyam, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1646 · Cited by 38
“Previous experiments have shown that administration of cytotoxic therapies (6, 25) or ECM degrading enzymes (9) can decrease solid stress and restore vascular function.”
RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy
Sanati, M., Afshari, A. R., Aminyavari, S., Kesharwani, P., Jamialahmadi, T., & Sahebkar, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104562 · Cited by 42
Yan, Z., Yang, Y., Wei, X., Zhong, J. Q., Wei, D., Liu, L., Xie, C., Wang, F., Zhang, L., Lu, W., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400393a · Cited by 39
Voutouri, C., Panagi, M., Mpekris, F., Stylianou, A., Michael, C., Averkiou, M. A., Martin, J. D., & Stylianopoulos, T. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000289 · Cited by 45
Biomedical,clinical and environmental applications of platinum-based nanohybrids: An updated review
Yerpude, S. T., Potbhare, A. K., Bhilkar, P. R., Rai, A. R., Singh, R. P., Abdala, A. A., Adhikari, R., Sharma, R., & Chaudhary, R. G. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116148 · Cited by 41
Lymphangiogenesis and hemangiogenesis: Potential targets for therapy
Witte, M. H., Dellinger, M. T., McDonald, D. M., Nathanson, D. S., Boccardo, F. M., Campisi, C., Sleeman, J. P., & Gershenwald, J. E. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21714 · Cited by 44
“In contrast, angiogenic BVCs, lacking tethering filaments between the endothelial cells, and with tightly closed interendothelial junctions are compressed by increased extracellular pressures exerted by increased IFP and by crowded growth of tumor cells [74].”
BackgroundThe buckling of capillaries in solid tumours
MacLaurin, J., Chapman, J., Jones, G. W., & Roose, T. (2012) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2012.0418 · Cited by 39
Hamad, I. M., & Moghimi, S. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.2.205 · Cited by 38
Welter, M., Fredrich, T., Rinneberg, H. H., & Rieger, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161267 · Cited by 44
“Elevated interstitial fluid pressure (IFP) is known to be a hallmark of tumors [10], primarily caused by the increased leakiness of tumor vessels and the lymph drain being impaired in solid tumors.”
BackgroundTao, Z., Yang, H., Shi, Q., Fan, Q., Wan, L., & Lu, X. (2017) · Theranostics · doi:10.7150/thno.19091 · Cited by 38
Mermod, M., Hiou‐Feige, A., Bovay, E., Roh, V., Sponarova, J., Bongiovanni, M., Vermeer, D. W., Lee, J. H., Petrova, T. V., Rivals, J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31240 · Cited by 37
Prescribing patterns in growing tubular soft matter by initial residual stress
Du, Y., Lü, C., Liu, C., Han, Z., Li, J., Chen, W., Qu, S., & Michel Destrade, A. (2019) · Soft Matter · doi:10.1039/c9sm01563a · Cited by 37
Influence of initial residual stress on growth and pattern creation for a layered aorta
Du, Y., Lü, C., Michel Destrade, A., & Chen, W. (2019) · Arrow@dit (Dublin Institute of Technology) · Cited by 37
Cron, G. O., Beghein, N., Crokart, N., Chavée, E., Bernard, S., Vynckier, S., Scalliet, P. G. M., & Gallez, B. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.971 · Cited by 37
VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels
Longatto‐Filho, A., Martins, A. M., Costa, S., & Schmitt, F. C. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.11.008 · Cited by 37
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology
Brocato, T. A., Dogra, P., Koay, E. J., Day, A., Chuang, Y.-L., Wang, Z., & Cristini, V. (2014) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0143-2 · Cited by 37
Biochemomechanical modeling of vascular collapse in growing tumors
Xue, S.-L., Yin, S., Li, B., & Feng, X. (2018) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2018.08.009 · Cited by 36
Urra, F. A., Fuentes-Retamal, S., Palominos, C., Rodríguez-Lucart, Y. A., López-Torres, C., & Araya‐Maturana, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751301 · Cited by 41
Targeting Tumor Physical Microenvironment for Improved Radiotherapy
Wang, J., Han, Y., Li, Y., Zhang, F., Cai, M., Zhang, X., Chen, J., Ji, C., Ma, J., & Xu, F. (2022) · Small Methods · doi:10.1002/smtd.202200570 · Cited by 41
The hamster cheek pouch model for field cancerization studies
Monti‐Hughes, A., Aromando, R. F., Pérez, M. A., Schwint, A. E., & Itoiz, M. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12066 · Cited by 36
Poljak‐Blaži, M., Kolarić, D., Jaganjac, M., Žarković, K., Skala, K., & Žarković, N. (2009) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2009.01.002 · Cited by 35
Singh, A., Nunes, J. J., & Ateeq, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.011 · Cited by 45
“This stress in the growing tumour collapses blood vessels and limits perfusion resulting in extensive hypoxia and impaired drug delivery (Griffon-Etienne et al., 1999; Janmey and McCulloch, 2007; Padera et al., 2004).”
BackgroundTansi, F. L., Fröbel, F., Maduabuchi, W. O., Steiniger, F., Westermann, M., Quaas, R., Teichgräber, U. K.-M., & Hilger, I. (2021) · Nanomaterials · doi:10.3390/nano11020438 · Cited by 39
“This is, in part, due to a high interstitial pressure of desmoplastic tumors, which collapse blood vessels and hinder tumor accessibility to therapeutics [9].”
Tehrani, M. H. H., Soltani, M., Kashkooli, F. M., Mahmoudi, M., & Raahemifar, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010035 · Cited by 37
“φL is assumed to be zero due to the absence of a lymph system inside the tumor [48,49].”
BackgroundHompland, T., Ellingsen, C., Galappathi, K., & Rofstad, E. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-92 · Cited by 38
“High cell density is associated with high resistance to interstitial fluid flow [23], and furthermore, cell division in rapidly growing tumors with high cell densities may cause mechanical pressure on vessel walls, leading to local vessel narrowings and, hence, increased resistance to blood flow [24].”
BackgroundMpekris, F., Papaphilippou, P. C., Panagi, M., Voutouri, C., Michael, C., Charalambous, A., Dinev, M. M., Katsioloudi, A., Prokopi, M., Anayiotos, A. S., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03305 · Cited by 37
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Patel, H. H., Li, J., Bo, L., Mehta, R., Ashby, C. R., Wang, S., Cai, W., & Chen, Z. (2024) · Medical Review · doi:10.1515/mr-2023-0058 · Cited by 45
da Silva, W., Costa, P. A. C., Scalzo, S., Ferreira, H. A. S., Prazeres, P. H. D. M., Campos, C., Alves, M. T. R., da Silva, N. J. A., Santos, A. L. D. C., Guimarães, L. C., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s452896 · Cited by 36
“22,23 This combination generates delivery barriers for therapeutics, even for delivery systems such as LNPs. 24 Therefore, TME normalization is a promising strategy to improve delivery.”
BackgroundLymphatic system regulation of anti-cancer immunity and metastasis
Lei, P., Fraser, C. S., Jones, D., Ubellacker, J. M., & Padera, T. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449291 · Cited by 45
“Inside tumors, lymphatic vessels are compressed (68, 81), possibly due to the solid stress exerted by growing cancer cells (32, 44, 45, 55, 56, 68, 82 – 86), but functional lymphatic vessels in the tumor periphery remain and can transport antigen and metastatic cancer cells.”
BackgroundSelf-citationPatil, S., Gentschev, I., Adelfinger, M., Donat, U., Heß, M., Weibel, S., Nolte, I. J. A., Frentzen, A., & Szalay, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047472 · Cited by 39
“ized by interstitial hypertension interferes with intratumoral spread (diffusion) of therapeutic agents [27].”
BackgroundBreaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals
Giri, T. K. (2018) · Current Drug Delivery · doi:10.2174/1567201815666180918112139 · Cited by 36
Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment
Porazinski, S. R., Parkin, A., & Pajic, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35582-1_6 · Cited by 36
Gengenbacher, N., Singhal, M., Mogler, C., Hai, L., Milde, L., Pari, A. A. A., Besemfelder, E., Fricke, C., Baumann, D., Gehrs, S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0122 · Cited by 37
The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia
Gallez, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853568 · Cited by 37
“It was also found that diphteria toxin decreased the interstitial fluid pressure in solid tumors (Padera et al., 2004).”
BackgroundYin, J., Dong, F., An, J., Guo, T., Cheng, H., Zhang, J., & Zhang, J. (2024) · Theranostics · doi:10.7150/thno.89306 · Cited by 41
Tumour vasculature: Friend or foe of oncolytic viruses?
Santry, L. A., van Vloten, J. P., Knapp, J. P., Matuszewska, K., McAusland, T. M., Minott, J. A., Mould, R. C., Stegelmeier, A. A., Major, P. P., Wootton, S. K., et al. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.007 · Cited by 37
Role of Regular Physical Exercise in Tumor Vasculature: Favorable Modulator of Tumor Milieu
Esteves, M., Monteiro, M. P., & Duarte, J. A. (2020) · International Journal of Sports Medicine · doi:10.1055/a-1308-3476 · Cited by 38
“[131] Padera TP, Stoll BR, Tooredman JB et al.”
BackgroundEichten, A., Hyun, W. C., & Coussens, L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4676 · Cited by 34
Leal‐Egaña, A., Fritsch, A. W., Heidebrecht, F., Díaz‐Cuenca, A., Nowicki, M., Bader, A., & Käs, J. A. (2012) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2012.01.013 · Cited by 35
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors
Komarla, A., Dufresne, S., & Towers, C. G. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad001 · Cited by 35
Milosevic, M., Pintilie, M., Hedley, D. W., Bristow, R. G., Wouters, B. G., Oza, A. M., Laframboise, S., Hill, R. P., & Fyles, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28403 · Cited by 31
“An important cause of high capillary resistance is rapid tumor proliferation in a noncompliant space leading to vessel compression.(21,22) Proliferation during RT is known to be an important determinant of outcome in patients with cervical cancer(23) and others have speculated that the addition of concurrent cisplatin…”
BackgroundForces During Cell Adhesion and Spreading: Implications for Cellular Homeostasis
Carey, S. P., Charest, J. M., & Reinhart‐King, C. A. (2010) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/8415_2010_22 · Cited by 34
“This stiffening is likely a result of increased interstitial tissue pressure and solid stress due to tumor expansion [120], an increase in the intracellular stiffness of malignant cells [121], excessive RhoA-based cell contractility [122, 123], and fibrosis [105].”
BackgroundZhang, Q., Jin, H., Chen, L., Chen, Q., He, Y., Yang, Y., Ma, S., Xiao, S., Xi, F., Luo, Q., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00716 · Cited by 32
Wen, Q., Yue, Y., Shang, J., Lü, X., Gao, L., & Hou, Y. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-2 · Cited by 32
“Squamous cell carcinoma, which is mainly formed by cancer cell stacking, manifests as a solid mass that can infringe on blood vessels, thus affecting the blood supply (34).”
BackgroundNanotechnology in Cancer Drug Therapy: A Biocomputational Approach
Frieboes, H. B., Sinek, J. P., Nalcioğlu, O., Fruehauf, J. P., & Cristini, V. (2007) · Springer eBooks · doi:10.1007/978-0-387-25842-3_15 · Cited by 36
“However, given the possibility that transport limitations through the abnormally constituted tumor vasculature may cause the drug concentration to be lower within the tumor [37, 48, 67 , 79], this assumption may not hold.”
BackgroundWijeratne, P. A., & Vavourakis, V. (2019) · Interface Focus · doi:10.1098/rsfs.2018.0063 · Cited by 31
Metadata
- Authors
- Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Nature
- Published
- 2004-02-19
- Volume
- 427
- Issue
- 6976
- Pages
- 695-695
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2014282546
- Cited by
- 857
- References
- 10
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 40 · 2023: 47 · 2022: 39 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 48 · 2015: 32 · 2014: 36 · 2013: 39 · 2012: 42
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor vasculature, tumor cell proliferation, vascular collapse, mechanical forces, lymphatic vessels, cytotoxic chemotherapy
- MeSH terms
- Animals, Cell Division, Diphtheria Toxin, Humans, Neoplasm Transplantation, Neoplasms, Transplantation, Heterologous, Reperfusion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.